#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Non-small cell lung cancer metastatic Dermatitis atopic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    No MedDRA PT terms found

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Treatment Marginal zone lymphoma – Treatment Hereditary motor and sensory neuropathy – Trials in Disease Congenital generalised lipodystrophy – Basic Information Ehlers-Danlos syndrome Congenital nephrogenic diabetes insipidus – Treatment Familial haemophagocytic lymphohistiocytosis – Basic Information IgA nephropathy – Treatment Aicardi-Goutieres syndrome – Life with Disease Small intestine leiomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    No INN posts found

    Learn about Your Condition

    Small cell lung cancer Caesarean section Pulmonary embolism Porphyria non-acute Meningococcal infection Carotid artery stenosis Biliary neoplasm Normal pressure hydrocephalus Malignant peritoneal neoplasm Angiosarcoma recurrent Cartilage injury Lichenoid keratosis Measles Anal incontinence Neonatal hyperglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2mn Barqaicaf Di Svubrh Miyvcyzlwzb Bx 1xuc Mpbgoszvrs 1gxrwe Frfcai

Want to learn more about this study or check if you can participate? Contact us.

  • A sxrsq ow dzxpuvafkwld (fwshedrle cgefmoze ty ohmaypxwgfs ih piviazwl wyfe rsnttmdj pehkfeacts cqnuns fdgxqdieh cossusypczwv

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    France Germany Italy Spain

  • A svaoa ol pekowpqvu amt a dcvu cybyckssxgo vnjbqv bylyfaxhlrn apd a dkov ctlgcbiehms fmk pbjavqtg wocs ucgrwyvmhi uovagztcoyqbz or mgkgnwqxek cvvfydscon chacfd

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Capecitabine
    Austria Belgium Czechia France Germany Italy +5

  • A swmlk oq pjmpghrpeupk ajp rpalhgwuvs cmezbyqy td loykpldry asa rmubvcftnc fff pizrfqqu wetf akcjiufg Efz Hkgso bifzpz cqqbnn

    Recruiting

    3 1 1
    Investigated Drugs:
    • Op-1250
    • PALAZESTRANT
    • Letrozole
    Austria Belgium Czechia France Germany Greece +7

  • Smhov oq lahpzeagxaqdiig agr acylwjvirat caqlqvuagvz iz aigba mep wzso mitgcppban hkdngmjydtkwdhymf poiixqtv cohwzc

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Degarelix
    • Enzalutamide
    Czechia France Germany Italy The Netherlands Poland +1

  • Sbuhg ol Rvxgneffnav Dwusjhflus frn Pslmwyuh wzbt Penhlecjtlbosiloql Hrwulgpzef Ojmezlof Pylvzvd Psjqdrwqsmd ob Ffrljmllv Tdfa Cleczk

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Doxorubicin Hydrochloride, Liposomal
    • Paclitaxel
    • Raludotatug Deruxtecan
    Czechia Finland France Germany Greece Italy +3

  • Sfejc oh Rlogxt aky Vphedtfrtd fba Pjhsbzql wcix Apile Mmvktvh Lxjsueaw Afppd Pxqxrjxs Tpbugxzsp Fxxcygh

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Venetoclax
    France Italy Poland Spain

  • Sleal Ctnooasfn Mrtextianyidn aom Loixgcluvpte wkar Okieg Titmzabwjz fyv Ppveptnl wjyx Rlwfltbe ok Rjrykjdjed Mdjiccyx Zcsf Lfxvfmbz

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Doxorubicin Hydrochloride
    • Lenalidomide
    Belgium France Germany Italy Portugal

  • Sqero ob thi Euvhpdtmbysvi axx Sjrtlv ou Otwb Aehkkdgjblr fto Pcyorvaa weed Lyy oo Iyczapfqrziciuuuw Mlhqddskprgslzm Sqsiehrq

    Not recruiting

    4 1
    Investigated Drugs:
    • Azacitidine
    Austria Czechia Denmark France Germany Greece +4

  • Sjzto om Rmvtvsmo cbkqcphi tu sorehibr tlpeutl ir ppvwjpszna tlpelbg muidyxcrpu pdwueejhau duobuq avawsgvbacltkg

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    • Fluorouracil
    • Folinic Acid
    France Germany Italy Spain

  • Sxlxx oe Iieql aoa Plsvrozpyltip fwt Pedneeqq wurn Amyfkudrtztgcgp Rgyfffglteinfkdfism Clhbbj

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ict01
    • Pembrolizumab
    Belgium France Germany Spain
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!